Escalon Medical Corp.
Moat Score — Escalon Medical Corp.
Total Moat Score
6 / 30
| Moat Factor | Score | Analysis |
|---|---|---|
| Intangible Assets Patents, trademarks, brand strength, or regulatory licenses that protect a company's products or services from being freely copied by competitors. | 1 / 5 | Holds only ~2 active U.S. patents (expiring ~2027) and FDA/ISO/CE regulatory clearances; management itself states products are driven more by trade secrets/know-how than patents, giving weak IP protection. |
| Cost Advantage A durable ability to produce goods or services more cheaply than competitors — through scale, unique access to cheap inputs, location, or process — that lets a company undercut rivals or out-earn them at the same price. | 1 / 5 | Tiny scale (~$12M revenue, two small plants) provides no purchasing or manufacturing cost edge versus large diversified ophthalmic device competitors. |
| Pricing Power The ability to raise prices without losing meaningful business, because the product or service is differentiated, mission-critical, or has few good substitutes. | 1 / 5 | Company explicitly competes on price against larger rivals in a market it says several large companies dominate; thin margins and a recent return to only marginal operating profit confirm limited pricing power. |
| Network Effect The product or service becomes more valuable to every user as more people or organizations use it, making an established leader harder to displace. | 0 / 5 | No network effects; ultrasound devices and surgical disposables are standalone clinical tools with no multi-sided platform or user-driven value growth. |
| Switching Costs The money, time, or operational disruption a customer would face switching to a competitor, which locks in existing customers and supports renewals. | 2 / 5 | Capital equipment installed base and clinician training/workflow familiarity create some modest switching friction, but optical biometry alternatives are increasingly substitutable, limiting durability. |
| Efficient Scale A market that can only profitably support a small number of players, so incumbents face limited threat from new entrants even without other defenses. | 1 / 5 | Niche ophthalmic ultrasound/disposables market is not naturally limited to one or two players; Escalon is a small sub-scale competitor rather than a dominant efficient-scale incumbent. |